IP Verse

Eli Lilly And Company competitive analysis

Latest oppositions filed by Eli Lilly And Company

Explore patent oppositions filed by Eli Lilly And Company against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
EP2784084
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses ThereofGENENTECHMar 16, 2020
EP3045182
Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide And Methods Using SameLABRYS BIOLOGICSDec 7, 2018
EP2475388
Use Of Il-33 Antagonists To Treat Fibrotic DiseaseMERCK SHARP & DOHMEAug 8, 2018
EP2579902
Method For Production Of F-18 Labeled Amyloid Beta LigandsPIRAMAL IMAGINGApr 12, 2018
EP1976558
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsBOEHRINGER INGELHEIMDec 14, 2017
EP2265288
Methods Of Treating Inflammatory PainLABRYS BIOLOGICSFeb 13, 2017
EP2371382
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsBOEHRINGER INGELHEIMDec 2, 2016
EP1745799
Compositions And Methods Of Treating TumorsTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJun 2, 2016
EP1868648
Methods And Compositions For Modulating Hyperstabilized C-MetGENENTECHJan 15, 2016
EP2281829
Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIMSep 16, 2015

Latest patents of Eli Lilly And Company opposed by its competitors

Explore Eli Lilly And Company's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3958838
Sep 10, 2025Method For Preparing Stable Peptide Formulations1
EP2247558
Jul 3, 2024Novel Imaging Agents For Detecting Neurological Dysfunction1
EP3668568
Jun 12, 2024Dosage Measurement Module On Injection Pen1
EP3432949
May 1, 2024Determination Of A Dose Set And Delivered In A Medication Delivery Device1
EP4017557
Feb 7, 2024Methods And Apparatus For Aspects Of A Dose Detection System1
EP3697476
Nov 15, 2023Accelerated Testing Method Of Silicone Drainage In Syringes1
EP3846810
Oct 18, 2023Chronic Nightly Dosing Of Lasmiditan For Migraine Prevention1
EP3630164
Aug 23, 2023Dulaglutide For The Treatment Of Chronic Kidney Disease1
EP3810201
Aug 2, 2023Gip/Glp1 Agonist Compositions8
EP3258919
Nov 9, 2022Nasal Powder Formulation For Treatment Of Hypoglycemia1

Latest PTAB cases involving Eli Lilly And Company

Discover the latest PTAB cases involving Eli Lilly And Company, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 28, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Eli Lilly And Company

IPR2025-01346Aug 4, 2025BPI LABSELI LILLYDiscretionary Denial
IPR2025-01024May 22, 2025EMPOWER CLINIC SERVICESELI LILLYDiscretionary Denial
IPR2022-00796Apr 11, 2022ELI LILLYTEVAFinal Written Decision
IPR2022-00796Apr 11, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2022-00738Mar 23, 2022ELI LILLYTEVAFinal Written Decision
IPR2022-00738Mar 23, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
IPR2022-00739Mar 23, 2022ELI LILLYTEVAFinal Written Decision
IPR2022-00739Mar 23, 2022ELI LILLYTEVA PHARMACEUTICALSFinal Written Decision
PGR2019-00043Apr 2, 2019ELI LILLYGENENTECHTerminated
IPR2018-01711Oct 1, 2018ELI LILLYTEVAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Eli Lilly And Company with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ELI LILLY9301715
BOEHRINGER INGELHEIM3619589
TEVA2 - - 12
TEVA PHARMACEUTICALS3161712